Strategies for rapid production of therapeutic proteins in mammalian cells

BioProcess International

Volumn 10, Issue 4, 2012, Pages 32-48

  Agrawal, Vishal ^a   Bal, Manjot ^b  

^a Aragen Bioscience   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Automation; Cell line engineering; Cell sorting; CHO cells; DHFR; Disposables; MTX; Serum free media; Transient transfection

Indexed keywords

ALBUMIN; BEVACIZUMAB; CD20 ANTIGEN; DACLIZUMAB; DIHYDROFOLATE REDUCTASE; ESCHERICHIA COLI PROTEIN; ETANERCEPT; GLUTAMATE AMMONIA LIGASE; GLYCAN; GREEN FLUORESCENT PROTEIN; GROWTH HORMONE; HUMAN INSULIN; IMMUNOGLOBULIN G; INFLIXIMAB; INSULIN; METHIONINE SULFOXIMINE; METHOTREXATE; MONOCLONAL ANTIBODY; OMALIZUMAB; PALIVIZUMAB; PLASMID DNA; POLYETHYLENEIMINE; RECOMBINANT DNA; RECOMBINANT PROTEIN; RITUXIMAB; TISSUE PLASMINOGEN ACTIVATOR; TRANSFERRIN; TRASTUZUMAB;

AUTOMATION; BIOLOGICAL THERAPY; BIOREACTOR; CELL STRAIN BHK; CHO CELL; CLONING; CRYOPRESERVATION; CULTURE MEDIUM; DRUG INDUSTRY; DRUG MARKETING; EXPRESSION VECTOR; FLUORESCENCE ACTIVATED CELL SORTING; FOOD AND DRUG ADMINISTRATION; GENE AMPLIFICATION; GENE EXPRESSION; GENE SEQUENCE; HIGH THROUGHPUT SCREENING; HUMAN; LARGE SCALE PRODUCTION; MAMMAL CELL; NONHUMAN; PROTEIN PROCESSING; PROTEIN SECRETION; REVIEW; TRANSCRIPTION INITIATION;

MAMMALIA;

EID: 84861683733     PISSN: 15426319     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Review

References (88)

1. Durocher Y, Butler M. Expression Systems for Therapeutic Glycoprotein Production. Curr. Opin. Biotechnol. 20, 2009: 700-707.
2. Birch JR, Onakunle Y. Biopharmaceutical Proteins: Opportunities and Challenges. Meth. Mol. Biol. 308, 2005: 1-16.
3. Baldi L, et al. Recombinant Protein Production By Large-Scale Transient Gene Expression in Mammalian Cells: State of the Art and Future Perspectives. Biotechnol. Lett. 29, 2007: 677-684. (Pubitemid 46569214)
4. Chu L, Robinson DK. Industrial Choices for Protein Production By Large-Scale Cell Culture. Curr. Opin. Biotechnol. 12, 2001: 180-187. (Pubitemid 32247406)
5. Pham PL, Kamen A, Durocher Y. Large-Scale Transfection of Mammalian Cells for the Fast Production of Recombinant Protein. Mol. Biotechnol. 34, 2006: 225-237. (Pubitemid 46030396)
6. Dingermann T. Recombinant Therapeutic Proteins: Production Platforms and Challenges. Biotechnol. J. 3, 2008: 90-97. (Pubitemid 351200935)
7. Hacker DL, De Jesus M, Wurm FM. 25 Years of Recombinant Proteins from Reactor-Grown Cells: Where Do We Go from Here? Biotechnol. Adv. 27, 2009: 1023-1027.
8. Wurm FM. Production of Recombinant Protein Therapeutics in Cultivated Mammalian Cells. Nat. Biotechnol. 22, 2004: 1393-1398. (Pubitemid 39482858)
9. Birch JR, Racher AJ. Antibody Production. Adv. Drug Deliv. Rev. 58, 2006: 671-685. (Pubitemid 44247226)
10. Jerums M, Yang X. Optimization of Cell Culture Media. BioProcess Int. 3(6) 2005: S38-S44.
11. Whitford W. NS0 Serum-Free Culture and Applications. BioProcess Int. 1(12) 2003: 36-47.
12. Decaria P, Smith A, Whitford W. Many Considerations in Selecting Bioproduction Culture Media. BioProcess Int. 7(1) 2009: 44-51.
13. Bibila TA, Robinson DK. In Pursuit of the Optimal Fed-Batch Process for Monoclonal Antibody Production. Biotechnol. Progr. 11, 1995: 1-13.
14. Cohen SN, et al. Construction of Biologically Functional Bacterial Plasmids in Vitro. Proc. Natl. Acad. Sci. USA 70, 1973: 3240-3244.
15. Bendig MM. The Production of Foreign Proteins in Mammalian Cells. Genet. Eng. 1988: 91-127.
16. Stark GR, Wahl GM. Gene Amplification. Ann. Rev. Biochem. 53, 1984: 447-491. (Pubitemid 14059147)
17. Schimke RT. Gene Amplification in Cultured Animal Cells. Cell 37, 1984: 705-713. (Pubitemid 15139270)
18. Kaufman RJ. Selection and Coamplification of Heterologous Genes in Mammalian Cells. Meth. Enzymol. 185, 1990: 537-566. (Pubitemid 20219847)
19. Kaufman RJ, et al. Expression, Purification, and Characterization of Recombinant Gamma-Carboxylated Factor IX Synthesized in Chinese Hamster Ovary Cells. J. Biolog. Chem. 261, 1986: 9622-9628. (Pubitemid 17214084)
20. Simonsen CC, Levinson AD. Isolation and Expression of an Altered Mouse Dihydrofolate Reductase cDNA. Proc. Natl. Acad. Sci. USA 80, 1983: 2495-2499. (Pubitemid 13093343)
21. Omasa T. Gene Amplification and Its Application in Cell and Tissue Engineering. J. Biosci. Bioeng. 94, 2002: 600-605. (Pubitemid 36132561)
22. Rath H, Tlsty T, Schimke RT. Rapid Emergence of Methotrexate Resistance in Cultured Mouse Cells. Cancer Res. 44, 1984: 3303-3306. (Pubitemid 14098572)
23. Jones SD, Castillo FJ, Levine HL. Advances in the Development of Therapeutic Monoclonal Antibodies. BioPharm Int. 20, 2007: 96-114. (Pubitemid 350105514)
24. Westwood AD, Rowe DA, Clarke HR. Improved Recombinant Protein Yield Using a Codon Deoptimized DHFR Selectable Marker in a CHEF1 Expression Plasmid. Biotechnol. Progr. 26, 2010: 1558-1566.
25. Kingston RE, et al. Amplification Using CHO Cell Expression Vectors. Curr. Prot. Mol. Biol. 1 November 2002: published online.
26. Cockett MI, Bebbington CR, Yarranton GT. High-Level Expression of Tissue Inhibitor of Metalloproteinases in Chinese Hamster Ovary Cells Using Glutamine Synthetase Gene Amplification. Biotechnol. 8, 1990: 662-667.
27. Barnes LM, Bentley CM, Dickson AJ. Advances in Animal Cell Recombinant Protein Production: GS-NS0 Expression System. Cytotechnol. 32, 2000: 109-123. (Pubitemid 30166226)
28. Bebbington CR, Hentschel CCG. The Use of Vectors Based on Gene Amplification for the Expression of Clones Genes in Mammalian Cells. Glover DM, Ed. (DNA Cloning, Vol. 3) Academic Press: San Diego, CA, 1987: 163.
29. Jun SC, et al. Limitations to the Development of Humanized Antibody Producing Chinese Hamster Ovary Cells Using Glutamine Synthetase-Mediated Gene Amplification. Biotechnol. Progr. 22, 2006: 770-780. (Pubitemid 43877445)
30. Kwaks TH, Otte AP. Employing Epigenetics to Augment the Expression of Therapeutic Proteins in Mammalian Cells. Trends Biotechnol. 24, 2006: 137-142.
31. Girod PA, et al. Genome-Wide Prediction of Matrix Attachment Regions That Increase Gene Expression in Mammalian Cells. Nat. Meth. 4, 2007: 747-753.
32. Kwaks TH, et al. Targeting of a Histone Acetyltransferase Domain to a Promoter Enhances Protein Expression Levels in Mammalian Cells. J. Biotechnol. 115, 2005: 35-46. (Pubitemid 39656431)
33. Williams S, et al. CpG-Island Fragments from the HNRPA2B1/CBX3 Genomic Locus Reduce Silencing and Enhance Transgene Expression from the hCMV Promoter/Enhancer in Mammalian Cells. BMC Biotechnol. 5, 2005: 17.
34. Oumard A, et al. Recommended Method for Chromosome Exploitation: RMCE-Based Cassette-Exchange Systems in Animal Cell Biotechnology. Cytotechnol. 50, 2006: 93-108.
35. Yarranton GT. Mammalian Recombinant Proteins: Vectors and Expression Systems. Curr. Opin. Biotechnol. 1, 1990: 133-140. (Pubitemid 120036506)
36. Wirth M, et al. Isolation of Overproducing Recombinant Mammalian Cell Lines By a Fast and Simple Selection Procedure. Gene 73, 1988: 419-426. (Pubitemid 19043273)
37. Kito M, et al. Construction of Engineered CHO Strains for High-Level Production of Recombinant Proteins. Appl. Microbiol. Biotechnol. 60, 2002: 442-448. (Pubitemid 35435814)
38. Huang Y, et al. An Efficient and Targeted Gene Integration System for High-Level Antibody Expression. J. Immunol. Meth. 322, 2007: 28-39. (Pubitemid 46560579)
39. Cacciatore JJ, Chasin LA, Leonard EF. Gene Amplification and Vector Engineering to Achieve Rapid and High-Level Therapeutic Protein Production Using the Dhfr-Based CHO Cell Selection System. Biotechnol. Adv. 28, 2010: 673-681.
40. Wirth D, et al. Road to Precision: Recombinase-Based Targeting Technologies for Genome Engineering. Curr. Opin. Biotechnol. 18, 2007: 411-419. (Pubitemid 350116585)
41. Zhou H, et al. Development of Site-Specific Integration System to High-Level Expression Recombinant Proteins in CHO Cells. Sheng Wu Gong Cheng Xue Bao 23, 2007: 756-762.
42. Kaufman WL, et al. Homogeneity and Persistence of Transgene Expression By Omitting Antibiotic Selection in Cell Line Isolation. Nucl. Acids Res. 36, 2008: e111.
43. Zhou H, et al. Generation of Stable Cell Lines By Site-Specific Integration of Transgenes into Engineered Chinese Hamster Ovary Strains Using an FLP-FRT System. J. Biotechnol. 147, 2010: 122-129.
44. Browne SM, Al-Rubeai M. Selection Methods for High-Producing Mammalian Cell Lines. Trends Biotechnol. 25, 2007: 425-432. (Pubitemid 350147111)
45. Carroll S, Al-Rubeai M. The Selection of High-Producing Cell Lines Using Flow Cytometry and Cell Sorting. Expert Opin. Biol. Ther. 4, 2004: 1821-1829. (Pubitemid 39518115)
46. Brezinsky SC, et al. A Simple Method for Enriching Populations of Transfected CHO Cells for Cells of Higher Specific Productivity. J. Immunol. Meth. 277, 2003: 141-155. (Pubitemid 36694381)
47. Sen S, Erba E, D'Incalci M. Synchronisation of Cancer Cell Lines of Human Origin Using Methotrexate. Cytometry 11, 1990: 595-602. (Pubitemid 20195430)
48. Meng YG, et al. Green Fluorescent Protein As a Second Selectable Marker for Selection of High-Producing Clones from Transfected CHO Cells. Gene 242, 2000: 201-207. (Pubitemid 30064506)
49. Bailey CG, Tait AS, Sunstrom NA. High-Throughput Clonal Selection of Recombinant CHO Cells Using a Dominant Selectable and Amplifiable Metallothionein-GFP Fusion Protein. Biotechnol. Bioeng. 80, 2002: 670-676. (Pubitemid 35364618)
50. DeMaria CT, et al. Accelerated Clone Selection for Recombinant CHO Cells Using a FACS-Based High-Throughput Screen. Biotechnol. Prog. 23, 2007: 465-472. (Pubitemid 46626323)
51. Yoshikawa T, et al. Flow Cytometry: An Improved Method for the Selection of Highly Productive Gene-Amplified CHO Cells Using Flow Cytometry. Biotechnol. Bioeng. 74, 2001: 435-442. (Pubitemid 32777459)
52. Caron AW, et al. Fluorescent Labeling in Semi-Solid Medium for Selection of Mammalian Cells Secreting High-Levels of Recombinant Proteins. BMC Biotechnol. 9, 2009: 42.
53. Durocher Y, Perret S, Kamen A. High-Level and High-Throughput Recombinant Protein Production By Transient Transfection of Suspension-Growing Human 293-EBNA1 Cells. Nucl. Acids Res. 30, 2002: E9.
54. Derouazi M, et al. Serum-Free Large-Scale Transient Transfection of CHO Cells. Biotechnol. Bioeng. 87, 2004: 537-545. (Pubitemid 39150055)
55. Galbraith DJ, et al. Control of Culture Environment for Improved Polyethylenimine-Mediated Transient Production of Recombinant Monoclonal Antibodies By CHO Cells. Biotechnol. Progr. 22, 2006: 753-762. (Pubitemid 43877444)
56. Haldankar R, et al. Serum-Free Suspension Large-Scale Transient Transfection of CHO Cells in WAVE Bioreactors. Mol. Biotechnol. 34, 2006: 191-199. (Pubitemid 46030392)
57. Van den Nieuwenhof IM, et al. Recombinant Glycodelin Carrying the Same Type of Glycan Structures As Contraceptive Glycodelin-A Can Be Produced in Human Kidney 293 Cells But Not in Chinese Hamster Ovary Cells. Europ. J. Biochem. (FEBS) 267, 2000: 4753-4762.
58. Ye J, et al. High-Level Protein Expression in Scalable CHO Transient Transfection. Biotechnol. Bioeng. 103, 2009: 542-551.
59. Kunaparaju R, Liao M, Sunstrom NA. Epi-CHO, an Episomal Expression System for Recombinant Protein Production in CHO Cells. Biotechnol. Bioeng. 91, 2005: 670-677. (Pubitemid 41283859)
60. Rajendra Y, et al. Reduced Glutamine Concentration Improves Protein Production in Growth-Arrested CHO-DG44 and HEK-293E cells. Biotechnol. Lett. November 2011: published online.
61. Rosser MP, et al. Transient Transfection of CHO-K1-S Using Serum-Free Medium in Suspension: A Rapid Mammalian Protein Expression System. Prot. Expr. Purif. 40, 2005: 237-243. (Pubitemid 40335905)
62. Diekmann SAD, et al. Single-Use Bioreactors for the Clinical Production of Monoclonal Antibodies: A Study to Analyze the Performance of a CHO Cell Line and the Quality of the Produced Monoclonal Antibody. BMC Proceedings 5, 2001: 103.
63. Wolfel J, et al. CAP-T Cell Expression Systems: A Novel Rapid and Versatile Human Cell Expression System for Fast and High-Yield Transient Protein Expression. BMC Proceedings 5, 2011: 133.
64. Muller N, et al. Scalable Transient Gene Expression in Chinese Hamster Ovary Cells in Instrumented and Noninstrumented Cultivation Systems. Biotechnol. Lett. 29, 2007: 703-711. (Pubitemid 46569215)
65. Spanggord RJ, et al. Application Note: An Accelerated Method for Production of Recombinant Proteins Using UCOE Expression Technolgy. Millipore Corporation: Billerica, MA, 2008.
66. Lucas BK, et al. High-level Production of Recombinant Proteins in CHO Cells Using a Dicistronic DHFR Intron Expression Vector. Nucl. Acids Res. 24, 1996: 1774-1779. (Pubitemid 26137939)
67. Girod P-A, et al. Rapid Production of Functional Proteins of a Combinatorial IgG Library in CHO Cells. BioProcess Int. 10(1) 2012: 58-61.
68. Ye J, et al. Rapid Protein Production Using CHO Stable Transfection Pools. Biotechnol. Progr. 26, 2010: 1431-1437.
69. Kost TA, Condreay JP. Recombinant Baculoviruses as Mammalian Cell Gene-Delivery Vectors. Trends Biotechnol. 20, 2002: 173-180. (Pubitemid 34242859)
70. Kost TA, et al. Implementation of BacMam Virus Gene Delivery Technology in a Drug Discovery Setting. Drug Discov. Today 12, 2007: 396-403. (Pubitemid 46646990)
71. Ames R, et al. BacMam Recombinant Baculoviruses in G Protein-Coupled Receptor Drug Discovery. Receptors Channels 10, 2004: 99-107. (Pubitemid 39504306)
72. Ashcroft SJ. The Beta-Cell K(ATP) Channel. J. Membr. Biol. 176, 2000: 187-206.
73. Mikhailov MV, Ashcroft SJ. Interactions of the Sulfonylurea Receptor 1 Subunit in the Molecular Assembly of Beta-Cell K(ATP) Channels. J. Biolog. Chem. 275, 2000: 3360-3364. (Pubitemid 30083040)
74. Condreay JP, et al. Baculoviruses and Mammalian Cell-Based Assays for Drug Screening. Adv. Virus Res. 68, 2006: 255-286. (Pubitemid 44402213)
75. Hassan NJ, et al. BacMam Recombinant Baculovirus in Transporter Expression: A Study of BCRP and OATP1B1. Prot. Expr Purif. 47, 2006: 591-598. (Pubitemid 43729033)
76. Boudjelal M, et al. The Application of BacMam Technology in Nuclear Receptor Drug Discovery. Biotechnol. Ann. Rev. 11, 2005: 101-125. (Pubitemid 41510275)
77. Abdelhamed AM, et al. Rebound of Hepatitis B Virus Replication in HepG2 Cells After Cessation of Antiviral Treatment. J. Virol. 76, 2002: 8148-8160. (Pubitemid 34809069)
78. Delaney WET, Isom HC. Hepatitis B Virus Replication in Human HepG2 Cells Mediated By Hepatitis B Virus Recombinant Baculovirus. Hepatol. 28, 1998: 1134-1146. (Pubitemid 28450278)
79. Nicholson LJ, et al. RNA Interference Mediated in Human Primary Cells Via Recombinant Baculoviral Vectors. Mol. Ther. 11, 2005: 638-644. (Pubitemid 40353121)
80. Kost TA, Condreay JP, Jarvis DL. Baculovirus As Versatile Vectors for Protein Expression in Insect and Mammalian Cells. Nat. Biotechnol. 23, 2005: 567-575. (Pubitemid 41724895)
81. Scott MJ, et al. Efficient Expression of Secreted Proteases Via Recombinant BacMam Virus. Prot. Expr. Purif. 52, 2007: 104-116. (Pubitemid 46043557)
82. Jardin BA, et al. Expression of SEAP (Secreted Alkaline Phosphatase) By Baculovirus Mediated Transduction of HEK 293 Cells in a Hollow-Fiber Bioreactor System. J. Biotechnol. 135, 2008: 272-280.
83. Dukkipati A, et al. BacMam System for High-Level Expression of Recombinant Soluble and Membrane Glycoproteins for Structural Studies. Prot. Expr. Purif. 62, 2008: 160-170.
84. Singh V. Disposable Bioreactor for Cell Culture Using Wave-Induced Agitation. Cytotechnol. 30, 1999: 149-158. (Pubitemid 29212114)
85. Eibl R, Loffelholz C, Eibl D. Single-Use Bioreactors: An Overview. Single-Use Techology in Biopharmaceutical Manufacture. John Wiley & Sons: Newark, NJ, 2011.
86. Gossain V, Mirro R. Linear Scale-Up of Cell Cultures: The Next Level in Disposable Bioreactor Design. BioProcess Int. 9(11) 2010: 56-62.
87. Smelko JP, et al. Performance of High-Intensity Fed-Batch Mammalian Cell Cultures in Disposable Bioreactor Systems. Biotechnol. Progr. 27, 2011: 1358-1364.
88. Eibl R, Eibl D. Disposable Bioreactors (Advances in Biochemical Engineering Biotechnology). Springer: Heidelberg, Germany, 2009.